Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.
Key facts
- Who runs it
- Santen SAS
- Where
- Denmark, France, Germany, Italy, Spain, Sweden, and United Kingdom10 sites in 7 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 344 people enrolled
- Started
- 29 Jul 2025
- Ended
- 17 Apr 2026
- Type of study
- Observational, 2 groups
- Record updated
- 22 May 2026
Who can take part
- Age
- 5 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their spherical equivalent (SER): Low myopia is from -0.5 D (inclusive) to -3.0 D (inclusive), Moderate myopia is from -3.0 D to -6.0 D (inclusive) and High myopia is <-6.0 D
- Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment
- Patients where myopia is a known or likely contributing factor to the complication
Who cannot take part
- Patients where the complication is likely unrelated to myopia (e.g., cataract caused by diabetes) will be excluded
- Parents (or other proxy) of children aged 4 years and below
This trial has no sites in United States.
It has sites in 7 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess the impact of myopia in childhood and its long-term complications in adulthood on health-related Quality of Life (HRQoL), providing valuable data for cost-effectiveness models. It will gather country-specific information on healthcare resource utilization, including treatment costs, access to care, and reimbursement policies. In addition, the study will examine how myopia and its treatments affect daily activities and evaluate treatment satisfaction. No data on the efficacy of myopia treatments is collected in this study, and neither is the occurrence of adverse events.
The 2 groups in the trial
- Childhood Myopia
Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their refractive error;
- Adulthood Myopia + Long-Term Complication
Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Non-interventional Study to Assess the Impact of Myopia in Childhood and the Long-Term Complications in Adulthood on Health-Related Quality of Life (HRQoL).
- Record updated
- 22 May 2026